MX351631B - Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos. - Google Patents

Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos.

Info

Publication number
MX351631B
MX351631B MX2014000878A MX2014000878A MX351631B MX 351631 B MX351631 B MX 351631B MX 2014000878 A MX2014000878 A MX 2014000878A MX 2014000878 A MX2014000878 A MX 2014000878A MX 351631 B MX351631 B MX 351631B
Authority
MX
Mexico
Prior art keywords
incidence
reducing
methods
compositions
digestive disorders
Prior art date
Application number
MX2014000878A
Other languages
English (en)
Other versions
MX2014000878A (es
Inventor
A Altman Jay
Original Assignee
Altera Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altera Int Ltd filed Critical Altera Int Ltd
Publication of MX2014000878A publication Critical patent/MX2014000878A/es
Publication of MX351631B publication Critical patent/MX351631B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001—Alpha-amylase (3.2.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención comprende composiciones y métodos para reducir la incidencia de trastornos digestivos equinos.
MX2014000878A 2011-07-22 2012-07-20 Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos. MX351631B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161510793P 2011-07-22 2011-07-22
PCT/US2012/047634 WO2013016205A2 (en) 2011-07-22 2012-07-20 Compositions and methods for reducing the incidence of equine digestive disorders

Publications (2)

Publication Number Publication Date
MX2014000878A MX2014000878A (es) 2014-03-21
MX351631B true MX351631B (es) 2017-10-23

Family

ID=47555911

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000878A MX351631B (es) 2011-07-22 2012-07-20 Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos.

Country Status (4)

Country Link
US (2) US8956590B2 (es)
CA (1) CA2843611C (es)
MX (1) MX351631B (es)
WO (1) WO2013016205A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351631B (es) 2011-07-22 2017-10-23 Altera Int Ltd Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos.
US10143218B1 (en) 2013-03-15 2018-12-04 Ac Nutrition, Lp Animal feed supplement
JP5866115B2 (ja) * 2013-04-17 2016-02-17 サントリーホールディングス株式会社 ラクトバチルス属菌
CA2908032A1 (en) 2013-04-17 2014-10-23 Suntory Holdings Limited Composition containing bacterium belonging to genus lactobacillus
US10939691B2 (en) * 2014-10-10 2021-03-09 Purina Animal Nutrition Llc Equine feed products and systems and methods of feeding same
US9694042B1 (en) * 2016-05-23 2017-07-04 Kaeco Group, Inc. Mastic gum top dressing for the prevention of gastrointestinal distress in horses and other species
CN108310238A (zh) * 2018-03-15 2018-07-24 武汉虹辰远荣生物制品有限公司 一种防治腹泻的益生菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595079B2 (en) 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
WO2007150052A1 (en) * 2006-06-23 2007-12-27 Equine Research Associates, Ltd Animal nutritional supplement and method
WO2008036719A2 (en) * 2006-09-19 2008-03-27 Powlen Owen J Animal feed supplements and uses thereof
US8883232B2 (en) * 2008-02-20 2014-11-11 Debra Baginski Horse feed and treatment methods
US20090252827A1 (en) * 2008-02-20 2009-10-08 Debra Baginski Horse feed and methods of treating horses
MX351631B (es) 2011-07-22 2017-10-23 Altera Int Ltd Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos.

Also Published As

Publication number Publication date
CA2843611C (en) 2021-07-27
US20130022576A1 (en) 2013-01-24
CA2843611A1 (en) 2013-01-31
WO2013016205A3 (en) 2013-04-04
US20150147297A1 (en) 2015-05-28
US9907840B2 (en) 2018-03-06
MX2014000878A (es) 2014-03-21
US8956590B2 (en) 2015-02-17
WO2013016205A2 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
PH12017500864A1 (en) Anti-notch1 antibodies
PH12015500525A1 (en) Formulations of enzalutamide
MX357923B (es) Polipéptidos antiinflamatorios no sialilados.
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
EP2714081A4 (en) METHODS, COMPOSITIONS AND KIT FOR CREAM TREATMENT
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
IN2014DN08481A (es)
MX354988B (es) Formulaciones de anticuerpo y metodos.
MX351631B (es) Composiciones y metodos para reducir la incidencia de trastornos digestivos equinos.
MX360710B (es) Antagonistas de il17c para el tratamiento de trastornos inflamatorios.
WO2011129936A3 (en) Compositions and methods for the prevention and treatment of cancer
EP2696874A4 (en) COMPOSITIONS AND METHODS USED TO TREAT NASAL CONDITIONS
MY167208A (en) Partially Hydrolyzed Casein-Whey Nutritional Compositions for Reducing the Onset of Allergies
IN2014DN09450A (es)
IL232710B (en) l-serine preparations, methods and uses for the treatment of neurodegenerative diseases and disorders
IN2013MU03641A (es)
MX2014001764A (es) Inhibidor de alfa1-proteinasa para demorar el comienzo o progresion de exacerbaciones pulmonares.
IN2014DN00254A (es)
IN2014CN00312A (es)
MX363385B (es) Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
EP2569018A4 (en) HUMANIZED TTC AND METHOD FOR ITS USE
MY168958A (en) Intermediates and processes for preparing compounds
IL227475A0 (en) Methods and kits for evaluating the pro-coagulation activity of heparanase' Preparations containing heparanase and methods for the treatment of disorders related to coagulation
IL223055A0 (en) Compositions for the treatment of gynaecological disorders

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ALTERA INTERNATIONAL LTD.

FG Grant or registration